Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing natural killer cell effector function against cancer. | Immunother Adv | 2024 | 38223411 | PubTator, text mining | PubMed |
| CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors. | Gastric Cancer | 2024 | 38221567 | PubTator, text mining | PubMed |
| Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. | Cell Commun Signal | 2024 | 38200509 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers in non-small cell lung carcinoma. | Pathology | 2024 | 38199926 | PubTator, text mining | PubMed |
| Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. | Histopathology | 2024 | 38196202 | PubTator, text mining | PubMed |
| Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model. | EJNMMI Radiopharm Chem | 2024 | 38194043 | PubTator, text mining | PubMed |
| Divergent epigenetic responses to perinatal asphyxia in severe mental disorders. | Transl Psychiatry | 2024 | 38191519 | PubTator, text mining | PubMed |
| Antibodies to watch in 2024. | MAbs | 2024 | 38178784 | PubTator, text mining | PubMed |
| The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors. | J Hematol Oncol | 2024 | 38178200 | PubTator, text mining | PubMed |
| High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. | Sci Rep | 2024 | 38177207 | PubTator, text mining | PubMed |
| Biology-driven therapy advances in high-grade serous ovarian cancer. | J Clin Invest | 2024 | 38165032 | PubTator, text mining | PubMed |
| Enrichment of sweat-derived extracellular vesicles of human and bacterial origin for biomarker identification. | Nanotheranostics | 2024 | 38164498 | PubTator, text mining | PubMed |
| MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer. | Int J Biol Sci | 2024 | 38164185 | PubTator, text mining | PubMed |
| FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect. | Heliyon | 2024 | 38163206 | PubTator, text mining | PubMed |
| Development of antibody-drug conjugates in cancer: Overview and prospects. | Cancer Commun (Lond) | 2024 | 38159059 | PubTator, text mining | PubMed |
| Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs). | Cancer Treat Rev | 2024 | 38118302 | PubTator, text mining | PubMed |
| Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial. | Ann Oncol | 2024 | 38092228 | PubTator, text mining | PubMed |
| Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma. | Cancer Biomark | 2024 | 38073379 | PubTator, text mining | PubMed |
| An electrochemical biosensor to assay Trop-2 of breast cancer cells fabricated by methylene blue-assisted assembly of DNA nanoparticles. | Biosens Bioelectron | 2024 | 38064995 | PubTator, text mining | PubMed |
| Expression Analysis of Early Metastatic Seeding of Colorectal Cancer. | Ann Surg Oncol | 2024 | 38063988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=41